Examkin

Soru

Zorluk: KolayRheumatology and Immunology

A 26-year-old woman presents to the physician to discuss recent laboratory results. She specifically requested an antinuclear antibody (ANA) screening after reading a health blog about autoimmune disorders, despite having no physical complaints. She explicitly denies any history of joint stiffness, photosensitive skin rashes, oral ulcers, profound fatigue, or weight changes. Her past medical history is unremarkable. Vital signs and a comprehensive physical examination are entirely within normal limits. The laboratory report reveals a positive ANA at a titer of 1:401:40 in a speckled pattern. The patient is highly distressed and wants to know her treatment options for systemic lupus erythematosus. Which of the following is the most appropriate next step in management?

  1. A
    Order a comprehensive serologic panel including anti-double-stranded DNA
  2. B
    Initiate empiric maintenance therapy with low-dose hydroxychloroquine
  3. Advise the patient that no further autoimmune evaluation is currently indicatedCevap
  4. D
    Prescribe a brief course of oral glucocorticoids to prevent disease progression
  5. E
    Refer the patient for baseline articular ultrasonography

Cevap

Advise the patient that no further autoimmune evaluation is currently indicated
In the absence of any clinical signs or symptoms, a low-titer positive ANA (such as 1:401:40) is a highly non-specific finding that occurs in a significant proportion of healthy individuals. A diagnosis of systemic lupus erythematosus (SLE) requires a combination of clinical and immunological criteria. Because this patient's pre-test probability for an autoimmune connective tissue disease is exceedingly low, the positive predictive value of this test is effectively zero. The most appropriate next step is to provide patient education that this is a normal variant and that no further diagnostic testing, referral, or treatment is indicated.

Adım Adım Çözüm

1
Evaluate the patient's clinical presentation.
The patient is completely asymptomatic, has no historical features of autoimmune disease, and has a normal physical examination.
A diagnosis of an autoimmune disease like systemic lupus erythematosus (SLE) requires both clinical criteria (e.g., arthritis, rash, serositis) and serologic evidence.
2
Interpret the laboratory findings within the clinical context.
The ANA is positive at a low titer of 1:401:40.
The ANA test is highly sensitive but poorly specific. Low-titer ANA results (1:401:40 to 1:801:80) can be found in up to 20% to 30% of completely healthy individuals.
3
Determine the appropriate management plan based on the pre-test probability.
No further testing or treatment is needed; reassurance is appropriate.
Because the patient's pre-test probability of SLE is near zero, the positive predictive value of this low-titer ANA is extremely low, representing a false positive or normal variant.

Anahtar Kavram

The positive predictive value of an ANA test is exceptionally low in asymptomatic individuals, and low-titer positive results (1:401:40 or 1:801:80) are frequently seen in healthy populations, requiring no further workup.
Tahmini Süre:50s
Bu soruyu puanla

Konular

Rheumatology and Immunology

Bu konudan daha fazla soru